{"SPADE_N_06554": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_06554", "Peptide Name": "MSI-238", "Source": "African clawed frog Xenopus laevis skin", "Family": "", "Gene": "Not found", "Sequence": "GIGKFLKKAKKFAKAFVKIINN", "Sequence Length": 22, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:A549 (IC50=6 ÂµM)", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Amidation", "Stereochemistry": "D", "Structure Description": "Not found", "Formula": "H-42O-21", "Mass": 2464.05, "PI": 10.78, "Net Charge": 7, "Hydrophobicity": 0.01, "Half Life": "Mammalian:/Yeast:/E.coli:/", "Comments": "A mechanism which appears to be related to short duration non-receptor-driven contact with target cell membranes.", "Literature": [{"Title": "Anticancer efficacy of Magainin2 and analogue peptides", "Pubmed ID": "8319212", "Reference": "Cancer Res. 1993 Jul 1;53(13)3052-7.", "Author": "Baker MA, Maloy WL, Zasloff M, Jacob LS.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=8319212"}], "Frequent Amino Acids": "KAF", "Absent Amino Acids": "CDEHMOPQRSTUWY", "Basic Residues": 7, "Acidic Residues": 0, "Hydrophobic Residues": 11, "Polar Residues": 13, "Positive Residues": 7, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_06554", "Similarity": 1.0, "Sequence": "GIGKFLKKAKKFAKAFVKIINN"}, {"SPADE_ID": "SPADE_N_10794", "Similarity": 1.0, "Sequence": "GIGKFLKKAKKF"}, {"SPADE_ID": "SPADE_N_10970", "Similarity": 1.0, "Sequence": "KWKLFKKIGIGKFL"}]}}}